ConductScience.org, home

Trial · NCT00985725

Results by group82

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Change From Baseline in Behavior Rating Inventory of Executive Function - Adult Version Global Executive Composite T-score (BRIEF-A GEC T) at Week 9, Last Observation Carried Forward (LOCF)Lisdexamfetamine Dimesylate (LDX)-21.2Standard Error 1.67T-scores
Change From Baseline in Behavior Rating Inventory of Executive Function - Adult Version Global Executive Composite T-score (BRIEF-A GEC T) at Week 9, Last Observation Carried Forward (LOCF)Placebo-13.2Standard Error 1.66T-scores
Change From Baseline in Montgomery-Ǻsberg Depression Rating Scale (MADRS) Total Score at Week 9 - (LOCF)Lisdexamfetamine Dimesylate (LDX)-5.0Standard Error 0.66Scores on a scale
Change From Baseline in Montgomery-Ǻsberg Depression Rating Scale (MADRS) Total Score at Week 9 - (LOCF)Placebo-3.1Standard Error 0.66Scores on a scale
Change From Baseline in BRIEF-A T-scores at Week 9, LOCFLisdexamfetamine Dimesylate (LDX)Behavioral recognition index-17.4Standard Error 1.51T-scores
Change From Baseline in BRIEF-A T-scores at Week 9, LOCFPlaceboBehavioral recognition index-12.3Standard Error 1.50T-scores
Change From Baseline in BRIEF-A T-scores at Week 9, LOCFLisdexamfetamine Dimesylate (LDX)Inhibit subscale-13.5Standard Error 1.26T-scores
Change From Baseline in BRIEF-A T-scores at Week 9, LOCFPlaceboInhibit subscale-9.3Standard Error 1.25T-scores
Change From Baseline in BRIEF-A T-scores at Week 9, LOCFLisdexamfetamine Dimesylate (LDX)Shift subscale-16.2Standard Error 1.51T-scores
Change From Baseline in BRIEF-A T-scores at Week 9, LOCFPlaceboShift subscale-10.6Standard Error 1.50T-scores
Change From Baseline in BRIEF-A T-scores at Week 9, LOCFLisdexamfetamine Dimesylate (LDX)Emotional control subscale-13.8Standard Error 1.48T-scores
Change From Baseline in BRIEF-A T-scores at Week 9, LOCFPlaceboEmotional control subscale-10.1Standard Error 1.47T-scores
Change From Baseline in BRIEF-A T-scores at Week 9, LOCFLisdexamfetamine Dimesylate (LDX)Self-monitor subscale-13.8Standard Error 1.36T-scores
Change From Baseline in BRIEF-A T-scores at Week 9, LOCFPlaceboSelf-monitor subscale-10.7Standard Error 1.35T-scores
Change From Baseline in BRIEF-A T-scores at Week 9, LOCFLisdexamfetamine Dimesylate (LDX)Metacognition index-21.1Standard Error 1.67T-scores
Change From Baseline in BRIEF-A T-scores at Week 9, LOCFPlaceboMetacognition index-12.2Standard Error 1.66T-scores
Change From Baseline in BRIEF-A T-scores at Week 9, LOCFLisdexamfetamine Dimesylate (LDX)Initiate subscale-19.4Standard Error 1.57T-scores
Change From Baseline in BRIEF-A T-scores at Week 9, LOCFPlaceboInitiate subscale-10.8Standard Error 1.56T-scores
Change From Baseline in BRIEF-A T-scores at Week 9, LOCFLisdexamfetamine Dimesylate (LDX)Working memory subscale-20.1Standard Error 1.65T-scores
Change From Baseline in BRIEF-A T-scores at Week 9, LOCFPlaceboWorking memory subscale-11.0Standard Error 1.64T-scores

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00985725/results